PRODUCTS
Online Inquiry

For Research Use Only. Not For Clinical Use.

Respiratory & Lung Organoid Model Products

Products
Introduction Breakthrough Excellence Portfolio Impact FAQsContact

Introduction

The human respiratory tract is a masterpiece of fluid dynamics, gas exchange, and mucosal immunity. Conventional 2D cultures completely fail to capture the coordinated ciliary beating, mucus secretion, and delicate alveolar structures of the native lung. At Creative Biolabs, we engineer highly calibrated reagent ecosystems designed to guide stem cells and primary basal cells through precise pulmonary specification, structural branching, and functional maturation.

By providing the targeted morphogen gradients and biophysical cues your 3D models demand, our formulations empower you to construct architecturally accurate airway and distal lung tissues in vitro.

Contact our scientific support team today to discuss your specific pulmonary protocols and receive a customized quote designed to accelerate your respiratory research.

Overcoming Pulmonary Culture Bottlenecks

Directing the formation of functional bronchospheres or alveolospheres requires masterful manipulation of developmental signaling. Without precise biochemical control, airway cultures often succumb to squamous metaplasia, while alveolar Type 2 (AT2) cells rapidly lose their surfactant-producing capabilities. Our specialized media directly resolve these tissue-specific hurdles:

Proximal vs. Distal Patterning

  • Our basal media and supplements delicately balance Wnt, FGF, and BMP pathways to accurately specify either the proximal conducting airways or the distal gas-exchanging alveoli, preventing mixed-identity cultures.

Mucociliary Competence

  • We provide targeted Notch-modulating cocktails that strictly control the ratio of goblet cells to ciliated cells, ensuring physiological mucus production and robust, coordinated ciliary beating.

AT2 Cell Stabilization

  • Culturing distal lung organoids requires extreme precision. Our alveolar formulations are uniquely enriched to sustain the expression of Surfactant Protein C (SFTPC), preventing the premature flattening of AT2 progenitors into AT1-like cells.

The Creative Biolabs Standard for Respiratory Assays

Air-Liquid Interface (ALI) Compatibility

Our reagent suites are strictly formulated to support both submerged 3D organoid expansion and seamless transition to transwell ALI cultures, promoting maximum epithelial maturation.

Unwavering Batch Reproducibility

Inhalation toxicology and cytokine assays demand a pristine background. We put every lot through exhaustive endotoxin screening and sterility testing. You receive a biologically clean foundation that guarantees your inflammatory readouts are genuine, not experimental noise.

Serum-Free Clarity

Animal-derived serum actively drives squamous differentiation in lung epithelia. Our core expansion and maturation media are 100% chemically defined and serum-free, preserving the true multipotency of your basal cells.

Targeted Reagent Suites for Lung Tissue Modeling

We offer a comprehensive portfolio tailored to the distinct functional zones of the respiratory system:

  • 1. Airway Basal Cell Expansion Media A highly proliferative, growth-factor-dense formulation that drives the rapid expansion of primary human bronchial epithelial cells (HBECs) while strictly maintaining their capacity for multi-lineage differentiation.
  • 2. Bronchial & Tracheal Maturation Cocktails Designed to trigger terminal differentiation. This supplement kit drives the emergence of functional ciliated cells, secretory club cells, and mucin-producing goblet cells, forming a complete mucociliary escalator.
  • 3. Distal Alveolosphere Differentiation Kits A specialized, serum-free environment optimized specifically for the derivation and long-term maintenance of AT2 cells, crucial for modeling distal lung regeneration and surfactant biology.
  • 4. Pulmonary-Optimized Extracellular Scaffolds Standard matrices often lack the necessary compliance. We supply dynamically tuned hydrogels that replicate the unique biochemical stiffness and laminin composition of healthy or fibrotic lung extracellular matrix.

Propelling Respiratory Discoveries

Our pulmonary portfolio is explicitly calibrated to empower your most critical preclinical endpoints:

  • Infectious Disease Virology: Maintain highly permissive models for studying respiratory pathogens, including Influenza A, RSV, and SARS-CoV-2, focusing on viral entry and host-pathogen interactions.
  • Cystic Fibrosis & Genetic Modeling: Replicate CFTR dysfunction using patient-derived cells to evaluate novel channel modulators and study airway fluid clearance.
  • Inhalation Toxicology: Perform highly predictive screening of aerosolized drugs, environmental pollutants, and particulates on functionally mature mucosal barriers.

Diagram illustrating cellular and assembly strategies for lung organoid construction.Fig.1 Cellular and assembly strategies of lung organoid construction.1

FAQs

  • 1. Can these reagents be used for both submerged organoids and ALI cultures?
    Yes. Our expansion media perfectly support the 3D submerged growth of bronchospheres, while our maturation cocktails are fully optimized to drive differentiation when your cells are seeded onto permeable supports for Air-Liquid Interface (ALI) culturing.
  • 2. Do your media support the maintenance of functional ciliary beating?
    Absolutely. By carefully modulating Notch and retinoic acid signaling, our maturation kits reliably induce dense ciliation with synchronized, active beating—a critical requirement for viral and toxicological assays.
  • 3. How do you prevent squamous metaplasia during long-term culture?
    Our media completely eliminate undefined serum and utilize specifically calibrated retinoic acid concentrations to suppress squamous differentiation, keeping the epithelium physiologically relevant.

How to Contact Us

Connect with our tissue engineering specialists at or dial +1-631-357-2254 to explore targeted reagent protocols and secure your laboratory's custom quotation.

Contact Us

Reference

  1. Zhang, Xingwu et al. "Advances and Applications of Lung Organoids in the Research on Acute Respiratory Distress Syndrome (ARDS)." Journal of clinical medicine vol. 13,2 346. 8 Jan. 2024. DOI: 10.3390/jcm13020346. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only. Not For Clinical Use.

Species Reactivity Human
Application Organoid Differentiation
Size 1 Kit (1T)
Species Reactivity Mouse
Application Dissociating organoids into individual cells or small cell clusters
Size 100 mL
Species Reactivity Mouse
Application Dissociating organoids into individual cells or small cell clusters
Size 100 mL
Species Reactivity Mouse
Application Culturing mouse alveolar tissue organoids
Size 2 (2 sample/Kit), 10 (10 sample/Kit)
Species Reactivity Mouse
Application Culturing mouse alveolar tissue organoids
Size 100 mL, 1000 mL
[Cat#: STV-0126-YJ27] Mouse Airway Organoid Culture Set
Species Reactivity Mouse
Application Establishment, Expansion
Size 100 mL, 500 mL
[Cat#: STV-0126-YJ35] Human Airway Organoid Culture Set
Species Reactivity Human
Application Establishment, Expansion
Size 100 mL, 500 mL
Species Reactivity Human
Application Establishment, Expansion
Size 100 mL, 500 mL
[Cat#: STV-0126-YJ30] Human Lung SCC Organoid Culture Set
Species Reactivity Human
Application Establishment, Expansion
Size 100 mL, 500 mL
[Cat#: STV-0126-YJ8] Human SCLC Organoid Culture Set
Species Reactivity Human
Application Establishment, Expansion
Size 100 mL, 500 mL
Species Reactivity Human
Application Establishment, Expansion
Size 100 mL, 500 mL